IN2014DN10134A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10134A
IN2014DN10134A IN10134DEN2014A IN2014DN10134A IN 2014DN10134 A IN2014DN10134 A IN 2014DN10134A IN 10134DEN2014 A IN10134DEN2014 A IN 10134DEN2014A IN 2014DN10134 A IN2014DN10134 A IN 2014DN10134A
Authority
IN
India
Prior art keywords
vesicular
active agent
biologically active
formulation
administering
Prior art date
Application number
Inventor
Richard Wolf Garraway
John Mayo
William Henry
Original Assignee
Sequessome Technology Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequessome Technology Holdings Ltd filed Critical Sequessome Technology Holdings Ltd
Publication of IN2014DN10134A publication Critical patent/IN2014DN10134A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to vesicular formulations for use in the topical administration of a biologically active agent, methods of administering a biologically active agent , a combined preparation comprising a vesicular formulation and a kit comprising a vesicular formulation.
IN10134DEN2014 2012-05-14 2013-05-10 IN2014DN10134A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201208384A GB201208384D0 (en) 2012-05-14 2012-05-14 Vesicular formulations, uses and methods
PCT/EP2013/059740 WO2013171131A1 (en) 2012-05-14 2013-05-10 Vesicular formulations, uses and methods

Publications (1)

Publication Number Publication Date
IN2014DN10134A true IN2014DN10134A (en) 2015-08-21

Family

ID=46458741

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10134DEN2014 IN2014DN10134A (en) 2012-05-14 2013-05-10

Country Status (9)

Country Link
US (1) US20150125407A1 (en)
EP (1) EP2849721A1 (en)
JP (1) JP2015516453A (en)
CN (1) CN104411298A (en)
DE (1) DE112013002492T5 (en)
GB (1) GB201208384D0 (en)
HK (1) HK1209027A1 (en)
IN (1) IN2014DN10134A (en)
WO (1) WO2013171131A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120129864A (en) 2009-08-21 2012-11-28 타겟티드 딜리버리 테크놀러지스 리미티드 Vesicular formulations
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
DK3316857T3 (en) 2015-06-30 2021-10-18 Sequessome Tech Holdings Limited MULTIFASIC COMPOSITIONS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0238554A4 (en) * 1985-09-27 1987-10-27 Univ California Liposome transdermal drug delivery system.
JP3765579B2 (en) 1990-08-24 2006-04-12 イーデーエーアー アーゲー Ultra-fine droplet preparation for active substance administration
US6165500A (en) 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
JPH06293615A (en) * 1992-08-25 1994-10-21 Nippon Oil & Fats Co Ltd Cosmetic comprising mixed lipid membranous vesicle
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
BRPI0719756A2 (en) * 2006-12-01 2014-01-21 Anterios Inc Amphiphilic Nanoparticles
ES2335636B1 (en) * 2008-02-29 2011-05-11 Lipotec, S.A. COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION OF MIXED MICELAS.
DE112010001765T5 (en) 2009-06-03 2012-12-27 George Langton Iliffe Formulations for the treatment of tissue depth pain
KR20120129864A (en) 2009-08-21 2012-11-28 타겟티드 딜리버리 테크놀러지스 리미티드 Vesicular formulations

Also Published As

Publication number Publication date
EP2849721A1 (en) 2015-03-25
CN104411298A (en) 2015-03-11
WO2013171131A1 (en) 2013-11-21
HK1209027A1 (en) 2016-03-24
JP2015516453A (en) 2015-06-11
DE112013002492T5 (en) 2015-02-19
GB201208384D0 (en) 2012-06-27
US20150125407A1 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
TN2012000611A1 (en) Formulations of rifaximin and uses thereof
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2013001677A (en) Stable formulations of linaclotide.
MX364992B (en) Nuclear transport modulators and uses thereof.
MX369121B (en) Aqueous pharmaceutical formulation of tapentadol for oral administration.
NZ631144A (en) Compositions and methods for transmucosal absorption
MY173215A (en) Acetylcysteine compositions and methods of use thereof
MX2014008284A (en) Delayed-release formulation for reducing the frequency of urination and method of use thereof.
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2014008283A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
NZ718163A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
MX2013008175A (en) Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof.
PH12014502619A1 (en) Novel dosage and formulation
PH12016500142A1 (en) Vesicles
MX357704B (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
TR200806300A2 (en) Solubility enhancing pharmaceutical formulation
BR112015027436A2 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
IN2014DN10134A (en)
ZA201404068B (en) The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents
MX2013010947A (en) Gallium complexes, pharmaceutical compositions and methods of use.
PH12015500070A1 (en) Pediatric oral liquid compositions containing nepadutant
IN2014CN04119A (en)
EA201690113A1 (en) VESICULAS